Capital Analysts LLC’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60K Sell
1,250
-144
-10% -$6.71K ﹤0.01% 914
2025
Q4
$67K Hold
1,394
﹤0.01% 857
2025
Q3
$66K Hold
1,394
﹤0.01% 826
2025
Q2
$67K Sell
1,394
-270
-16% -$13.8K ﹤0.01% 756
2025
Q1
$92K Buy
1,664
+204
+14% +$11K ﹤0.01% 660
2024
Q4
$70K Sell
1,460
-77
-5% -$3.92K ﹤0.01% 691
2024
Q3
$88K Buy
1,537
+1,460
+1,896% +$78.8K ﹤0.01% 604
2024
Q2
$4K Buy
77
+21
+38% +$1.01K ﹤0.01% 1067
2024
Q1
$3K Hold
56
﹤0.01% 1032
2023
Q4
$3K Buy
56
+42
+300% +$2.05K ﹤0.01% 1000
2023
Q3
$1K Buy
+14
New +$746 ﹤0.01% 1141
2022
Q4
Sell
-86
Closed -$3K 1151
2022
Q3
$3K Buy
+86
New +$3.83K ﹤0.01% 960
2021
Q3
Sell
-157
Closed -$8K 1028
2021
Q2
$8K Buy
157
+111
+241% +$5.79K ﹤0.01% 776
2021
Q1
$2K Hold
46
﹤0.01% 983
2020
Q4
$2K Buy
+46
New +$2.27K ﹤0.01% 699
2020
Q1
Sell
-26
Closed -$1K 733
2019
Q4
$1K Buy
+26
New +$1.22K ﹤0.01% 704
2015
Q2
Sell
-154
Closed -$7.64K 394
2015
Q1
$7.64K Hold
154
﹤0.01% 353
2014
Q4
$7.04K Hold
154
﹤0.01% 357
2014
Q3
$8.72K Hold
154
﹤0.01% 346
2014
Q2
$8.21K Buy
+154
New +$8.17K ﹤0.01% 345

Other funds holding SNY

Capital Analysts LLC's SNY Position: Q1 2026 in Review

Capital Analysts LLC reduced its Sanofi (SNY) stake by 10% in Q1 2026, selling an estimated $6.71K and leaving 1,250 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Capital Analysts LLC first reported a position in SNY in Q2 2014 and has held it in 20 quarters since. The position peaked at $92K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Capital Analysts LLC held 1,250 shares of Sanofi worth $60K as of Q1 2026.
  • Capital Analysts LLC sold 144 Sanofi shares in Q1 2026, an estimated $6.71K.
  • Sanofi made up ﹤0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #914 holding.
  • Capital Analysts LLC first reported a position in Sanofi in Q2 2014 and has held it in 20 quarters since.
  • Capital Analysts LLC's Sanofi position peaked at $92K in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.